Your browser doesn't support javascript.
loading
Exacerbation of Chronic Spontaneous Urticaria Following Coronavirus Disease 2019 (COVID-19) Vaccination in Omalizumab-Treated Patients.
Lee, Ji-Hyang; Shin, Eunyong; Kim, Hyun-Kyoung; Song, Woo-Jung; Kwon, Hyouk-Soo; Kim, Tae-Bum; Cho, You Sook.
Affiliation
  • Lee JH; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address: gogoportia@gmail.com.
  • Shin E; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim HK; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Song WJ; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kwon HS; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim TB; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Cho YS; Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Allergy Clin Immunol Pract ; 11(8): 2403-2410, 2023 08.
Article in En | MEDLINE | ID: mdl-37182571

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria / COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria / COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2023 Document type: Article Country of publication: